Education
- Fellowship in Surgical and Medical Glaucoma: Toronto Western Hospital and the University of Toronto, Canada (2005-2006)
- Ophthalmology Residency: University of Ottawa, Ottawa, Ontario, FRCSC (2004)
- Doctorate of Medicine, Summa Cum Laude, University of Ottawa (1999)
- Master of Science, Neuromuscular Physiology and Biochemistry, Laurentian University, Sudbury, Ontario (1995)
- Honours Bachelor of Science, Chemistry, Laurentian University, Sudbury, Ontario (1993)
Dr Campbell is a Scientist with the Institute for Clinical Evaluative Sciences and leads an internationally-recognized, CIHR-funded health services research program focused on the assessment of eye and vision health care quality, access and safety. Dr Campbell’s research has had significant national and international impact and has been published in major journals such as BMJ and CMAJ.
Dr Campbell was recently named as the inaugural David Barsky Chair in Ophthalmology and Visual Sciences, by the Queen’s University Faculty of Health Sciences.
Dr Campbell holds positions in numerous health policy organizations and is Co-chair of Health Quality Ontario’s Glaucoma Quality Standards Expert Committee and a member of the Ontario Provincial Vision Care Task Force. Prior to assuming the role of Deputy Chair, Dr Campbell served as the Queen’s University Ophthalmology Residency Program Director. Dr Campbell studied medicine at the University of Ottawa, where he graduated Summa Cum Laude. He completed his residency in ophthalmology at the University of Ottawa, followed by fellowship training in glaucoma surgery at the University of Toronto and cornea surgery at Moorfields Eye Hospital in London, England.
Selected Health Care System Leadership and Administration Positions
Co-Chair, Ontario Ministry of Health and Long-Term Care Glaucoma Quality Standards Expert Committee
Ontario Ministry of Health and Long Term Care Provincial Vision Task Force
Eye Health Council of Ontario
Ontario Ministry of Health and Long Term Care Corneal Surgery Quality-Based Procedure Expert Group
Ontario Ministry of Health and Long Term Care Integrated Retinal Care Quality-Based Procedure Expert Group
Ontario Ministry of Health and Long Term Care Cataract Surgery Quality-Based Procedure Expert Group
Committee to Evaluate Drugs, Ontario Ministry of Health and Long-term Care - Consultant Advisor.
Advisor, Canadian Institute for Health Information.
Alberta Health Retina Anti-Vascular Endothelial Growth Factor Program for Intraocular Disease (RAPID) Safety Monitoring Committee
Selected Journal Publications
Campbell RJ, El-Defrawy SR, Bell CM, et al. Public funding for private for-profit centres and access to cataract surgery by patient socioeconomic status: an Ontario population-based study. CMAJ. 2024;196(28):E965-E972. doi:10.1503/cmaj.240414
Doliszny K, Quinn MP, El-Defrawy SR., Gill SS, Whitehead M, Johnson D, Campbell RJ, 2024. Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis. Can J Ophthalmol 59, 89–95. https://doi.org/10.1016/j.jcjo.2022.11.008
Javadian F, Pattathil N, Farmer J, Campbell, RJ, 2024. Isolated case of noninfectious and nontraumatic panophthalmitis. Can J Ophthalmol S0008-4182(24)00234–5. https://doi.org/10.1016/j.jcjo.2024.07.011
Sankar A., Stukel TA, Baxter NN, Wijeysundera DN, Hwang SW, Wilton AS, Chan TCY, Sarhangian V., Simpson AN, de Mestral C, Pincus D, Campbell RJ, Urbach DR, Irish J, Gomez D, 2024. Disparities in surgery rates during the COVID-19 pandemic: retrospective study. BJS Open 8, zrae088. https://doi.org/10.1093/bjsopen/zrae088
Stephenson R, Sarhangian V, Park J, et al. Evolution of the surgical procedure gap during and after the COVID-19 pandemic in Ontario, Canada: cross-sectional and modelling study. Br J Surg. 2023;110(12):1887-1889. doi:10.1093/bjs/znad289
Gomez D, de Mestral C, Stukel TA, et al. Characterizing the Impact of Procedure Funding on the Covid-19 Generated Procedure Gap in Ontario: A Population-Based Analysis. Ann Surg. 2023;278(4):e719-e725. doi:10.1097/SLA.0000000000005781
Quinn MP, Kratky V, Whitehead M, Gill SS, McIsaac MA, Campbell RJ. Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition. Eye (Lond). 2023;37(11):2233-2239. doi:10.1038/s41433-022-02322-w
Hatch WV, Leung V, Ahmed I, et al. Ontario Cataract Quality Outcome Initiative: appropriateness and prioritization of cataract surgery. Can J Ophthalmol. 2023;58(4):382-390. doi:10.1016/j.jcjo.2022.05.010
Nguyen AX, Salh D, Gatzios E, Robbins C, Campbell R, Sukhai M. Self-reported health and social well-being of adults living with vision loss during the COVID-19 pandemic. Can J Ophthalmol. Published online July 20, 2023:S0008-4182(23)00204-1. doi:10.1016/j.jcjo.2023.07.002
Campigotto A, Campbell RJ, Lai Y. Correlation between corneal and contact lens deformation with changes in intraocular pressure for wearable monitoring systems. Eye (Lond). 2023;37(10):2055-2060. doi:10.1038/s41433-022-02285-y
Liddy C, Guglani S, Ratzlaff T, et al. Expanding the scope of an eConsult service: acceptability and feasibility of an optometry-ophthalmology pilot project. Can J Ophthalmol. 2023;58(3):204-211. doi:10.1016/j.jcjo.2022.01.007
de Jager P, Aleman D, Baxter N, et al. Social determinants of access to timely elective surgery in Ontario, Canada: a cross-sectional population level study. CMAJ Open. 2023;11(6):E1164-E1180. doi:10.9778/cmajo.20230001
Fine A, Pike D, Campbell RJ, Gonder T. Intraocular foreign bodies: a subtle clinical emergency. CJEM. 2022;24(8):893-895. doi:10.1007/s43678-022-00389-8
Doliszny K, Quinn MP, El-Defrawy SR, et al. Evolution of first-line glaucoma therapy, 2007–2018: a population-based analysis. Canadian Journal of Ophthalmology. Published online December 2022:S000841822200360X. doi:10.1016/j.jcjo.2022.11.008
Sayal AP, Ahmed Y, Popovic MM, et al. Supply and demographic characteristics of Ontario’s ophthalmologists from 2010 to 2019: a population-based analysis. cmajo. 2022;10(4):E1067-E1078. doi:10.9778/cmajo.20210319
Newsted D, Cooke B, Rosen E, Nguyen P, Campbell RJ, Beyea JA. Hearing aid utilization in Ontario - a population based study. Disabil Rehabil Assist Technol. Published online August 2, 2022:1-7. doi:10.1080/17483107.2022.2091168
Yu S, Tam ALC, Campbell R, Renwick N. Emerging Evidence of Noncoding RNAs in Bleb Scarring after Glaucoma Filtration Surgery. Cells. 2022;11(8):1301. doi:10.3390/cells11081301
Felfeli T, Ximenes R, Naimark DMJ, et al. The ophthalmic surgical backlog associated with the COVID-19 pandemic: a population-based and microsimulation modelling study. CMAJ Open. 2021;9(4):E1063-E1072. doi:10.9778/cmajo.20210145
Kirubalingam K, Nguyen P, Klar G, Dion JM, Campbell RJ, Beyea JA. Opioid Prescriptions Following Otologic Surgery: A Population-Based Study. Otolaryngol Head Neck Surg. Published online September 28, 2021:1945998211045364. doi:10.1177/01945998211045364
Beyea JA, Newsted D, Campbell RJ, Nguyen P, Alkins RD. Response To Letter To The Editor: “Artificial Intelligence and Decision-Making For Vestibular Schwannoma Surgery.” Otol Neurotol. Published online August 5, 2021. doi:10.1097/MAO.0000000000003319
Alkins RD, Newsted D, Nguyen P, Campbell RJ, Beyea JA. Predictors of Postoperative Complications in Vestibular Schwannoma Surgery-A Population-Based Study. Otol Neurotol. 2021;42(7):1067-1073. doi:10.1097/MAO.0000000000003107
Quinn MP, Johnson D, Whitehead M, Gill SS, Campbell RJ. Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study. Ophthalmol Glaucoma. 2021;4(4):358-364. doi:10.1016/j.ogla.2020.11.001
Dion JMM, Campbell RJ, Nguyen P, Beyea JA. Preoperative anesthesiology consult utilization in Ontario - a population-based study. J Eval Clin Pract. Published online June 30, 2021. doi:10.1111/jep.13595
Quinn MP, Johnson D, Whitehead M, Gill SS, Campbell RJ. Distribution and Predictors of Initial Glaucoma Care Among Ophthalmologists and Optometrists: A Population-based Study. J Glaucoma. 2021;30(6):e300-e304. doi:10.1097/IJG.0000000000001792
Campbell RJ, El-Defrawy SR, Gill SS, et al. Surgical Outcomes among Focused versus Diversified Cataract Surgeons. Ophthalmology. 2021;128(6):827-834. doi:10.1016/j.ophtha.2021.01.016
Campigotto A, Ralhan A, Helgason R, Campbell RJ, Lai Y. Effect of variations of corneal physiology on novel non-invasive intraocular pressure monitoring soft contact lens. Biomed Microdevices. 2021;23(1):16. doi:10.1007/s10544-021-00555-2
Campbell RJ, Ten Hove MW, Bell CM, et al. Exclusive cataract surgical focus among ophthalmologists: a population-based analysis. Can J Ophthalmol. 2020;55(5):359-365. doi:10.1016/j.jcjo.2020.05.003
Rullo J, Bae S, Far PM, et al. Measuring intraocular antibodies in eyes treated with anti-vascular endothelial growth factor. Can J Ophthalmol. 2020;55(3):263-271. doi:10.1016/j.jcjo.2019.11.010
Campbell RJ, Sutherland R, Khan S, et al. Diabetes-induced eye disease among First Nations people in Ontario: a longitudinal, population-based cohort study. CMAJ Open. 2020;8(2):E282-E288. doi:10.9778/cmajo.20200005
Rullo J, Pennimpede T, Mehraban Far P, Strube YN, Irrcher I, Urton T, Bona M, Gonder T, Campbell RJ, Ten Hove M, Sharma S, Farmer J, Petkovich M. Intraocular calcidiol: Uncovering a role for vitamin D in the eye. J Steroid Biochem Mol Biol. 2019 Nov 14;197:105536.
Campbell RJ, El-Defrawy SR, Gill SS, Whitehead M, Campbell EdeLP, Hooper PL, Bell CM, Ten Hove MW. Evolution in the Risk of Cataract Surgical Complications among Patients Exposed to Tamsulosin: A Population-Based Study. Ophthalmology. 2019 Apr;126(4):490–496.
Campbell RJ, El-Defrawy SR, Gill SS, Whitehead M, Campbell EdeLP, Hooper PL, Bell CM, ten Hove MW. Cataract surgical outcomes among late-career surgeons: A population-based cohort study. JAMA Ophthalmology. 2019 Jan 1;137(1):58–64.
Bae SS, Campbell RJ. Glaucoma drainage device erosion following ptosis surgery. J Glaucoma. 2017;26(9):e200–1.
Campbell RJ, El-Defrawy SR, Bell CM, Gill SS, Hooper PL, Whitehead M, Campbell EdeL, Nesdole R, Warder D, ten Hove M. Effect of cataract surgery volume constraints on recently graduated ophthalmologists: a population-based cohort study. Can Med Assoc J. 2017;189(11):E424–30.
Xu K, Campbell EL, Gill SS, Nesdole R, Campbell RJ. Impact of Combination Glaucoma Therapies on β-Blocker Exposure. J Glaucoma. 2017 Feb;26(2):e107-e109.
Campbell RJ, El-Defrawy SR, Gill SS, Whitehead M, Campbell EL, Hooper PL, Bell CM, Ten Hove M. New Surgeon Outcomes and the Effectiveness of Surgical Training: A Population-Based Cohort Study. Ophthalmology. 2017;124(4):532-8.
Campbell RJ, El-Defrawy SR. Shaping the future of ophthalmology in Canada. Can J Ophthalmol. 2016 Dec;51(6):397-399.
Johnson D, El-Defrawy SR, Hollands S, Hurst J, Law C, Li C, Baxter S, Campbell Ede L, Campbell RJ. Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario. Can J Ophthalmol. 2016 Jun;51(3):168-73.
Campbell RJ, Gill SS, ten Hove M, El-Defrawy SR, Strube YNJ, Whitehead M, Campbell EdeLP, Bell CM. Strabismus surgical subspecialization: A population-based analysis. JAMA Ophthalmology. 2015;133(5):555-9.
Campbell RJ, Bell CM, Bronskill SE, Paterson MJ, Whitehead M, Campbell E de L, Gill SS. Adverse gastrointestinal events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study. Drug Safety. 2014;37(9):723-33.
Jinapriya D, D'Souza M, Hollands H, El-Defrawy SR, Irrcher I, Smallman D, Farmer JP, Cheung J, Day A, Sun X, Campbell RJ. Anti-inflammatory therapy after selective laser trabeculoplasty: A randomized, double-blind, placebo-controlled clinical trial. Ophthalmology. 2014;121(12):2356-61.
Campbell RJ, Bell CM, Gill SS, Whitehead M, Campbell E de L, El-Defrawy SR. Clinic-based glaucoma care in the era of surgical subspecialization. Am J Ophthalmol. 2014;157(3):631-9.e2
Campbell RJ, Bell CM, Campbell EdeL, Gill SS. Systemic effects of intravitreal vascular endothelial growth factor inhibitors. Curr Opin Ophthalmol. 2013;24(3):197-204.
Campbell RJ, Bell CM, Gill SS, Trope GE, Buys YM, Whitehead M, El-Defrawy SR. Subspecialization in Glaucoma Surgery. Ophthalmology. 2012;119(11):2270-3.
* Canadian Glaucoma Society – Merck Frosst Award - Best Glaucoma Publication, 2013.
Campbell RJ, Bell CM, Paterson JM, Bronskill SE, Moineddin R, Whitehead M, Gill SS. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis. Ophthalmology. 2012;119(8):1604-8.
Campbell RJ, Gill SS, Bronskill SE, Paterson JM, Whitehead M, Bell CM. Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study. BMJ. 2012;345:e4203.
Campbell RJ, Dhalla IA, Gill SS, Bell CM. Implications of "not me" drugs for health systems: lessons from age related macular degeneration. BMJ. 2012;344:e2941.
Health Policy Reports
Health Quality Ontario and The Ontario Provincial Vision Task Force. Glaucoma Care for Adults – Quality Standards. Toronto, Canada: 2018.
Ontario Ministry of Health and Long-Term Care Cornea Surgery Quality-Based Procedure Expert Group. Quality-based procedures Clinical Handbook for Integrated Corneal Transplant Care. Toronto, Canada: 2017.
Ontario Provincial Vision Strategy Task Force. Considerations for low risk adult ophthalmology procedures in community-based specialty clinics. Toronto, Canada: 2014.
Ontario Ministry of Health and Long Term Care Retina Quality-Based Procedure Expert Group. Quality-based procedures clinical handbook for integrated retinal care. Toronto, Canada: Dec 2014.
Ontario Ministry of Health and Long Term Care Cataract Surgery Quality-Based Procedure Expert Group. Quality indicators for cataract quality-based procedures: Baseline results. Toronto, Canada: Oct 2014.
Ontario Ministry of Health and Long Term Care Cataract Surgery Quality-Based Procedure Expert Group. Quality-based procedures clinical handbook for cataract surgery. Toronto, Canada: Jan 2013 (updated Oct 2013).
Ontario Provincial Vision Strategy Task Force. A vision for Ontario: Strategic recommendations for ophthalmology in Ontario. Toronto, Canada: May 2013.
Selected Major Research Grants
Canadian Institutes of Health Research Project Scheme Operating Grant (2016-2019).
Project: Comparative Safety of Aflibercept and Ranibizumab in the Treatment of Retinal Diseases. Principal Investigator.
Canadian Institutes of Health Research Operating Grant (2010-2015).
Project: Cardiovascular and Ocular Adverse Events Associated with New Treatments for Age-Related Macular Degeneration. Principal Investigator.
Collaborative Health Research Projects Grant, jointly funded by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) (2012-2015).
Project: Laser-Adjustable Sutures for Glaucoma Trabeculectomy Surgery. Co-Principal Investigator.